Cited by

• QSAR modeling: where have you been? Where are you going to?

  Cherkasov A, Muratov EN, Fourches D, Varnek A, Baskin II, Cronin M, Dearden J, Gramatica P, Martin YC, Todeschini R, Consonni V, Kuz'min VE, Cramer R, Benigni R, Yang C, Rathman J, Terfloth L, Gasteiger J, Richard A, Tropsha A. Cherkasov A, et al. J Med Chem. 2014 Jun 26;57(12):4977-5010. doi: 10.1021/jm4004285. Epub 2014 Jan 6. J Med Chem. 2014. PMID: 24351051 Free PMC article.
• CNS Anticancer Drug Discovery and Development Conference White Paper.

  Levin VA, Tonge PJ, Gallo JM, Birtwistle MR, Dar AC, Iavarone A, Paddison PJ, Heffron TP, Elmquist WF, Lachowicz JE, Johnson TW, White FM, Sul J, Smith QR, Shen W, Sarkaria JN, Samala R, Wen PY, Berry DA, Petter RC. Levin VA, et al. Neuro Oncol. 2015 Nov;17 Suppl 6(Suppl 6):vi1-26. doi: 10.1093/neuonc/nov169. Neuro Oncol. 2015. PMID: 26403167 Free PMC article.
• Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening.

  Mueller R, Rodriguez AL, Dawson ES, Butkiewicz M, Nguyen TT, Oleszkiewicz S, Bleckmann A, Weaver CD, Lindsley CW, Conn PJ, Meiler J. Mueller R, et al. ACS Chem Neurosci. 2010 Apr 21;1(4):288-305. doi: 10.1021/cn9000389. Epub 2010 Jan 28. ACS Chem Neurosci. 2010. PMID: 20414370 Free PMC article.
• Best Practices for QSAR Model Reporting: Physical and Chemical Properties, Ecotoxicity, Environmental Fate, Human Health, and Toxicokinetics Endpoints.

  Piir G, Kahn I, García-Sosa AT, Sild S, Ahte P, Maran U. Piir G, et al. Environ Health Perspect. 2018 Dec;126(12):126001. doi: 10.1289/EHP3264. Environ Health Perspect. 2018. PMID: 30561225 Free PMC article. Review.
• In memoriam professor Corwin Hansch: birth pangs of QSAR before 1961.

  Fujita T. Fujita T. J Comput Aided Mol Des. 2011 Jun;25(6):509-17. doi: 10.1007/s10822-011-9450-0. Epub 2011 Jun 22. J Comput Aided Mol Des. 2011. PMID: 21695492 No abstract available.